Critical evaluation of 1H NMR metabonomics of serum as a methodology for disease risk assessment and diagnostics.
about
Novel methodologies for biomarker discovery in atherosclerosisTranslational and emerging clinical applications of metabolomics in cardiovascular disease diagnosis and treatment.Untargeted LC-MS metabolomics of bronchoalveolar lavage fluid differentiates acute respiratory distress syndrome from health.Advances in NMR-based biofluid analysis and metabolite profilingMetabonomic, transcriptomic, and genomic variation of a population cohort.Metabolomic profiling for identification of novel potential biomarkers in cardiovascular diseases.Metabolic consequences of sepsis-induced acute lung injury revealed by plasma ¹H-nuclear magnetic resonance quantitative metabolomics and computational analysisLipoprotein subclass metabolism in nonalcoholic steatohepatitis.Human metabolic profiles are stably controlled by genetic and environmental variation.The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnessesEffects of 34 risk loci for type 2 diabetes or hyperglycemia on lipoprotein subclasses and their composition in 6,580 nondiabetic Finnish men.1H NMR metabonomics approach to the disease continuum of diabetic complications and premature deathAssociation between serum fatty acids and lipoprotein subclass profile in healthy young adults: exploring common genetic and environmental factors.Association of height and pubertal timing with lipoprotein subclass profile: exploring the role of genetic and environmental effects.Metabolomics-based methods for early disease diagnosticsLarge-scale human metabolic phenotyping and molecular epidemiological studies via 1H NMR spectroscopy of urine: investigation of borate preservation.Subacute exposure to N-ethyl perfluorooctanesulfonamidoethanol results in the formation of perfluorooctanesulfonate and alters superoxide dismutase activity in female rats.Cross-sectional and longitudinal associations of circulating omega-3 and omega-6 fatty acids with lipoprotein particle concentrations and sizes: population-based cohort study with 6-year follow-up.Implications of torcetrapib failure for the future of HDL therapy: is HDL-cholesterol the right target?Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy.Integration of datasets from different analytical techniques to assess the impact of nutrition on human metabolomeMetabolomics as a diagnostic tool in gastroenterology.Metabolic profiling of synovial fluid in a unilateral ovine model of anterior cruciate ligament reconstruction of the knee suggests biomarkers for early osteoarthritis.Gram-negative and Gram-positive bacterial infections give rise to a different metabolic response in a mouse modelMetabolic profiling of polycystic ovary syndrome reveals interactions with abdominal obesity.Metabolic profiling-multitude of technologies with great research potential, but (when) will translation emerge?Lipoprotein subclass profiles in individuals with varying degrees of glucose tolerance: a population-based study of 9399 Finnish men.Triglyceride-cholesterol imbalance across lipoprotein subclasses predicts diabetic kidney disease and mortality in type 1 diabetes: the FinnDiane Study.Mild cognitive impairment associates with concurrent decreases in serum cholesterol and cholesterol-related lipoprotein subclasses.Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Large-Scale Epidemiology: A Primer on -Omic Technologies.Hemoglobin level and lipoprotein particle size.Metabolomics in cardiovascular medicine: Not personalised, not diagnostic.Optimization of a direct analysis in real time/time-of-flight mass spectrometry method for rapid serum metabolomic fingerprinting.High-throughput quantification of circulating metabolites improves prediction of subclinical atherosclerosisCharacterization of systemic metabolic phenotypes associated with subclinical atherosclerosis
P2860
Q28088373-13FA9F33-B803-458D-8186-D8A7CAC67A1BQ31082889-EC35C3D8-9C40-4B7C-98E5-AAC76EA49FEEQ33799183-9FB3CCA3-FD38-4493-9C84-E1E38C2D636DQ34109340-305DCDE0-2D07-43EC-B649-3DABE3F0B2B5Q34476823-9DCE5114-A77F-4237-B5B0-AB77B88134DAQ34497155-C5AEF2C8-5227-4B25-A7E5-EE7A9B6F3859Q34502201-7E0E2EE0-229A-4B03-91BC-7017FCE38BE3Q34565315-F958ECE4-254A-4C38-9C7D-46324D136EB7Q35458562-5AD8FE92-66A0-4C13-8831-B757A4B6A638Q35527861-4B385A56-A9A1-4B65-B225-447D245D95AEQ35797050-2FE659E4-27F9-4CFC-9F2B-54DBB81C6F31Q36496258-901CE9EB-B9F6-4CA3-A2E0-7FFCF646979FQ36782235-49ABBADA-C519-4851-8B91-97B952C90C36Q36807488-F7A5A9C4-10C9-4875-995C-4BCF6FA29759Q37266489-E8A9B167-E2B6-48CA-9E51-17E8328C1268Q37292221-01C8C7B9-E6C4-462C-88D7-23E9D22685B0Q37371216-8D11BE93-9C8B-44B6-853F-127099DCCC35Q37580358-D49AF8A9-D16A-4252-B90D-8D2B400D7E78Q37707402-37CD069E-B2CC-4FC6-9E87-64E086199DB6Q37780690-A26D13D3-1D0F-45B5-9571-9583F3DDD174Q38068188-B102F685-A8F4-405A-B37F-99FD9F9EFE04Q38160492-31177788-F244-4872-AA26-DDC90625414DQ39118534-2F1B1F82-8C70-49B4-92DF-33AC7ADBBF88Q39631903-B48C4C84-5EC6-4718-ACEF-F4BEA14FB97AQ40184611-173B754A-E445-484D-A629-C0F20567FD51Q42372131-303C5DF3-E4CE-430D-AA4C-60A36EBA9416Q43552189-3AE83CC1-2F6B-42EF-93E5-6DFB7F04A54BQ45145247-C36D5972-55B0-43FC-9BC2-02065DBB4C51Q45415934-DB3B45D9-728B-44C6-B7BD-F5E41680114DQ47652764-F6249D66-1FB9-4C94-9C9F-D1BD8472CB72Q49242192-9ED67D34-2CC4-4C0A-9517-A107D031AACEQ50130288-0F435FE0-F2FD-4856-A9D3-BD16127CD5F9Q51889802-C62D2447-F32F-42BC-A07B-153CBFA1620AQ57417389-B36E3D37-C72A-408D-8E44-6AA74FC77E44Q57417403-3F306F74-94F1-4A8F-85F4-9799BE9F9B3D
P2860
Critical evaluation of 1H NMR metabonomics of serum as a methodology for disease risk assessment and diagnostics.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Critical evaluation of 1H NMR ...... sk assessment and diagnostics.
@en
Critical evaluation of 1H NMR ...... sk assessment and diagnostics.
@nl
type
label
Critical evaluation of 1H NMR ...... sk assessment and diagnostics.
@en
Critical evaluation of 1H NMR ...... sk assessment and diagnostics.
@nl
prefLabel
Critical evaluation of 1H NMR ...... sk assessment and diagnostics.
@en
Critical evaluation of 1H NMR ...... sk assessment and diagnostics.
@nl
P2860
P356
P1476
Critical evaluation of 1H NMR ...... sk assessment and diagnostics.
@en
P2860
P356
10.1515/CCLM.2008.006
P577
2008-01-01T00:00:00Z